Benzyl 2-amino-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate, 95.0%, 1g

1-Piperidinepentanol>98.0%(GC)(T)5g

(S)-4-Amino-4-phenylbutan-1-ol hydrochloride, 95.0%, 250mg

(2S,4S)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid, 95.0%, 100mg

7-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 1g

L-(-)-limoneno, mínimo 95 %, 100 ml, envase de vidrio

cis-1-Benzyl-N,4-dimethylpiperidin-3-amine, 95.0%, 1g

Bexarotene, Free Acid, 95.0%, 50mg

(3-Trifluoromethyl-1H-pyrazol-4-yl)methanol, 95.0%, 100mg

2,4-Dimethoxyiodobenzene>98.0%(GC)10g

Benzo[h]quinazolin-2-amine, 6-(2-fluorophenyl)-5,6-dihydro-N-[3-[2-[(2-methoxyethyl)amino]ethyl]phenyl]-, (6R)-, 99%, 50mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-cyclohexylacetic acid, 97%, 250mg

Viales de rosca estériles independientes, 1,5 ml, 1000 pieza(s)